Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1996-3-5
pubmed:abstractText
CA242 has been proved to be useful in the diagnosis of pancreatic cancer. The aim of the present study was to clarify the mechanisms contributing to the high specificity of CA242 as compared with CA19-9 resulting from scarce serum elevation of this antigen in patients with chronic pancreatitis by correlating serum levels and endoscopic retrograde choledocho-pancreatography (ERCP) findings and by immunohistochemical analysis. Serum CA19-9 levels were significantly elevated in patients with calcification and with main pancreatic duct (MPD) stenosis or obstruction. On the other hand, serum CA242 levels showed no significant elevation in patients with such factors. Even though such pathological conditions were considered to lead to the stagnation of pancreatic juice, serum CA242 levels seemed to be less affected than serum CA19-9 levels. Immunohistochemical studies of chronic pancreatitis tissues revealed that CA242 was expressed less frequently and less intensely than CA19-9, and the difference in expression was more prominent in the centroacinar cells and terminal ductules. From the results of the present study, it is conceivable that CA242 is less influenced by the stagnation of the pancreatic juice than CA19-9 because of the low levels of expression in ductal systems, which results in the release of this antigen into the circulation in lower amounts than that of CA19-9.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8562344-1316775, http://linkedlifedata.com/resource/pubmed/commentcorrection/8562344-1678888, http://linkedlifedata.com/resource/pubmed/commentcorrection/8562344-1712509, http://linkedlifedata.com/resource/pubmed/commentcorrection/8562344-1712758, http://linkedlifedata.com/resource/pubmed/commentcorrection/8562344-1739620, http://linkedlifedata.com/resource/pubmed/commentcorrection/8562344-1896821, http://linkedlifedata.com/resource/pubmed/commentcorrection/8562344-2021550, http://linkedlifedata.com/resource/pubmed/commentcorrection/8562344-2557879, http://linkedlifedata.com/resource/pubmed/commentcorrection/8562344-2984045, http://linkedlifedata.com/resource/pubmed/commentcorrection/8562344-3167774, http://linkedlifedata.com/resource/pubmed/commentcorrection/8562344-3465666, http://linkedlifedata.com/resource/pubmed/commentcorrection/8562344-3863691, http://linkedlifedata.com/resource/pubmed/commentcorrection/8562344-6381289, http://linkedlifedata.com/resource/pubmed/commentcorrection/8562344-6825270, http://linkedlifedata.com/resource/pubmed/commentcorrection/8562344-7142214, http://linkedlifedata.com/resource/pubmed/commentcorrection/8562344-7531332, http://linkedlifedata.com/resource/pubmed/commentcorrection/8562344-8080734, http://linkedlifedata.com/resource/pubmed/commentcorrection/8562344-8080735, http://linkedlifedata.com/resource/pubmed/commentcorrection/8562344-8431849, http://linkedlifedata.com/resource/pubmed/commentcorrection/8562344-8448851
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0007-0920
pubmed:author
pubmed:issnType
Print
pubmed:volume
73
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
372-6
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Comparative study of CA242 and CA19-9 in chronic pancreatitis.
pubmed:affiliation
Second Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't